Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 68
Filter
1.
Neurochem Res ; 49(5): 1347-1358, 2024 May.
Article in English | MEDLINE | ID: mdl-38353896

ABSTRACT

Previously, we reported that epidermal growth factor (EGF) suppresses GABAergic neuronal development in the rodent cortex. Parvalbumin-positive GABAergic neurons (PV neurons) have a unique extracellular structure, perineuronal nets (PNNs). PNNs are formed during the development of PV neurons and are mainly formed from chondroitin sulfate (CS) proteoglycans (CSPGs). We examined the effect of EGF on CSPG production and PNN formation as a potential molecular mechanism for the inhibition of inhibiting GABAergic neuronal development by EGF. In EGF-overexpressing transgenic (EGF-Tg) mice, the number of PNN-positive PV neurons was decreased in the cortex compared with that in wild-type mice, as in our previous report. The amount of CS and neurocan was also lower in the cortex of EGF-Tg mice, with a similar decrease observed in EGF-treated cultured cortical neurons. PD153035, an EGF receptor (ErbB1) kinase inhibitor, prevented those mentioned above excess EGF-induced reduction in PNN. We explored the molecular mechanism underlying the effect of EGF on PNNs using fluorescent substrates for matrix metalloproteinases (MMPs) and a disintegrin and metalloproteinases (ADAMs). EGF increased the enzyme activity of MMPs and ADAMs in cultured neurons. These enzyme activities were also increased in the EGF-Tg mice cortex. GM6001, a broad inhibitor of MMPs and ADAMs, also blocked EGF-induced PNN reductions. Therefore, EGF/EGF receptor signals may regulate PNN formation in the developing cortex.


Subject(s)
Epidermal Growth Factor , GABAergic Neurons , Neocortex , Animals , Mice , Epidermal Growth Factor/metabolism , Epidermal Growth Factor/pharmacology , ErbB Receptors/metabolism , Extracellular Matrix/metabolism , GABAergic Neurons/metabolism , Matrix Metalloproteinases/metabolism , Neocortex/metabolism , Parvalbumins/metabolism , Rodentia/metabolism
2.
Sensors (Basel) ; 23(9)2023 May 01.
Article in English | MEDLINE | ID: mdl-37177645

ABSTRACT

Optimizing the bias modulation of a fiber-optic gyroscope is crucial to improving its precision. In this study, we propose and demonstrate the use of multiple harmonics of sinusoidal modulation as an intermediate alternative to the widely used modulation methods: sinusoidal and square-wave modulation. We show that this alternative integrates the advantages of each modulation method by providing a smooth modulation that produces a clean, spike-free output and a satisfactory signal-to-noise ratio. By using three harmonics of modulation in combination with a high frequency to reduce thermal phase noise, we obtained an angular random walk of 5.2(2)µdeg/h and a bias instability of ∼10µdeg/h. This is the highest performance ever reported for fiber-optic gyroscopes.

3.
Cell Rep ; 42(5): 112398, 2023 05 30.
Article in English | MEDLINE | ID: mdl-37083330

ABSTRACT

Spatiotemporal control of gene expression is important for neural development and function. Here, we show that heterogeneous nuclear ribonucleoprotein (hnRNP) A/B is highly expressed in developing olfactory sensory neurons (OSNs), and its knockout results in reduction in mature OSNs and aberrant targeting of OSN axons to the olfactory bulb. RNA immunoprecipitation analysis reveals that hnRNP A/B binds to a group of mRNAs that are highly related to axon projections and synapse assembly. Approximately 11% of the identified hnRNP A/B targets, including Pcdha and Ncam2, encode cell adhesion molecules. In Hnrnpab knockout mice, PCDHA and NCAM2 levels are significantly reduced at the axon terminals of OSNs. Furthermore, deletion of the hnRNP A/B-recognition motif in the 3' UTR of Pcdha leads to impaired PCDHA expression at the OSN axon terminals. Therefore, we propose that hnRNP A/B facilitates OSN maturation and axon projection by regulating the local expression of its target genes at axon terminals.


Subject(s)
Olfactory Receptor Neurons , Animals , Mice , Axons/metabolism , Mice, Knockout , Neural Cell Adhesion Molecules/metabolism , Neurogenesis/genetics , Olfactory Bulb , Olfactory Receptor Neurons/metabolism , Presynaptic Terminals/metabolism
4.
Cancers (Basel) ; 14(3)2022 Feb 02.
Article in English | MEDLINE | ID: mdl-35159037

ABSTRACT

Multimodal therapy including surgery, radiation treatment, and temozolomide (TMZ) is performed on glioblastoma (GBM). However, the prognosis is still poor and there is an urgent need to develop effective treatments to improve survival. Molecular biological analysis was conducted to examine the signal activation patterns in GBM specimens and remains an open problem. Advanced macrolides, such as azithromycin, reduce the phosphorylation of p70 ribosomal protein S6 kinase (p70S6K), a downstream mammalian target of rapamycin (mTOR) effector, and suppress the proliferation of T-cells. We focused on its unique profile and screened for the antitumor activity of approved macrolide antibiotics. Clindamycin (CLD) reduced the viability of GBM cells in vitro. We assessed the effects of the candidate macrolide on the mTOR pathway through Western blotting. CLD attenuated p70S6K phosphorylation in a dose-dependent manner. These effects on GBM cells were enhanced by co-treatment with TMZ. Furthermore, CLD inhibited the expression of the O6-methylguanine-DNA methyltransferase (MGMT) protein in cultured cells. In the mouse xenograft model, CLD and TMZ co-administration significantly suppressed the tumor growth and markedly decreased the number of Ki-67 (clone MIB-1)-positive cells within the tumor. These results suggest that CLD suppressed GBM cell growth by inhibiting mTOR signaling. Moreover, CLD and TMZ showed promising synergistic antitumor activity.

5.
Neuropathology ; 42(2): 126-133, 2022 Apr.
Article in English | MEDLINE | ID: mdl-35026865

ABSTRACT

We describe a postmortem case of familial idiopathic basal ganglia calcification (FIBGC) in a 72-year-old Japanese man. The patient showed progressive cognitive impairment with a seven-year clinical course and calcification of the basal ganglia, thalami, and cerebellar dentate nuclei. A novel heterozygous missense variant in SLC20A2 (c.920C>T/p.P307L), a type III sodium-dependent phosphate transporter (PiT-2), was subsequently identified, in addition to typical neuropathological findings of FIBGC, such as capillary calcification of the occipital gray matter, confluent calcification of the basal ganglia and cerebellar white matter, widespread occurrence of vasculopathic changes, cerebrovascular lesions, and vascular smooth muscle cell depletion. Immunohistochemistry for PiT-2 protein revealed no apparent staining in endothelial cells in the basal ganglia and insular cortex; however, the immunoreactivity in endothelial cells of the cerebellum was preserved. Moreover, Western blot analysis identified preserved PiT-2 immunoreactivity signals in the frontal cortex and cerebellum. The variant identified in the present patient could be associated with development of FIBGC and is known to be located at the large intracytoplasmic part of the PiT-2 protein, which has potential phosphorylation sites with importance in the regulation of inorganic phosphate transport activity. The present case is an important example to prove that FIGBC could stem from a missense variant in the large intracytoplasmic loop of the PiT-2 protein. Abnormal clearance of inorganic phosphate in the brain could be related to the development of vascular smooth muscle damage, the formation of cerebrovascular lesions, and subsequent brain calcification in patients with FIBGC with SLC20A2 variants.


Subject(s)
Basal Ganglia Diseases , Endothelial Cells , Aged , Basal Ganglia Diseases/pathology , Calcinosis , Endothelial Cells/metabolism , Humans , Male , Neurodegenerative Diseases , Phosphates/metabolism , Sodium-Phosphate Cotransporter Proteins, Type III/genetics , Transcription Factor Pit-1/metabolism
6.
Neurochem Res ; 47(9): 2632-2644, 2022 Sep.
Article in English | MEDLINE | ID: mdl-34984589

ABSTRACT

Neuronal differentiation, maturation, and synapse formation are regulated by various growth factors. Here we show that epidermal growth factor (EGF) negatively regulates presynaptic maturation and synapse formation. In cortical neurons, EGF maintained axon elongation and reduced the sizes of growth cones in culture. Furthermore, EGF decreased the levels of presynaptic molecules and number of presynaptic puncta, suggesting that EGF inhibits neuronal maturation. The reduction of synaptic sites is confirmed by the decreased frequencies of miniature EPSCs. In vivo analysis revealed that while peripherally administrated EGF decreased the levels of presynaptic molecules and numbers of synaptophysin-positive puncta in the prefrontal cortices of neonatal rats, EGF receptor inhibitors upregulated these indexes, suggesting that endogenous EGF receptor ligands suppress presynaptic maturation. Electron microscopy further revealed that EGF decreased the numbers, but not the sizes, of synaptic structures in vivo. These findings suggest that endogenous EGF and/or other EGF receptor ligands negatively modulates presynaptic maturation and synapse formation.


Subject(s)
Epidermal Growth Factor , Synapses , Animals , Axons , Cells, Cultured , Epidermal Growth Factor/pharmacology , Neurogenesis/physiology , Neurons/metabolism , Rats , Synapses/metabolism
7.
FASEB J ; 36(2): e22160, 2022 02.
Article in English | MEDLINE | ID: mdl-35064699

ABSTRACT

Dopamine in the prefrontal cortex is essential for the regulation of social behavior. However, stress-causing social withdrawal also promotes dopamine release in the prefrontal cortex. Thus, this evidence suggests opposite functions of dopamine in the prefrontal cortex. However, the influence of dopamine on prefrontal functions is yet to be fully understood. Here, we show that dopamine differentially modulated the neuronal activity triggered by social stimuli in the prefrontal cortex, depending on the duration of the dopamine activation (transient or sustained activation). Using chemogenetic techniques, we have found that social behavior was negatively regulated by a sustained increase in dopamine neuronal activity in the ventral tegmental area, while it was positively regulated by an acute increase. The duration of social interactions was positively correlated with the transient dopamine release triggered by social stimuli in the prefrontal cortex and negatively correlated with the sustained increase in prefrontal dopamine levels. Furthermore, the elevation of neural calcium signal, triggered by social stimuli, in the prefrontal cortex was attenuated by the persistent elevation of prefrontal dopamine levels, whereas an acute increase in dopamine levels enhanced it. Additionally, the chronic excess of dopamine suppressed c-Fos induction triggered by social stimuli in prefrontal neurons expressing dopamine D1 receptors, but not D2 receptors. These results suggest that sustained activation of prefrontal dopamine, at the opposite of its transient activation, can reduce prefrontal activity associated with social behavior, even for identical dopamine concentrations. Thus, dopamine plays opposite roles in modulating prefrontal activity depending on the duration of its action.


Subject(s)
Dopamine/metabolism , Prefrontal Cortex/metabolism , Animals , Dopaminergic Neurons/metabolism , Male , Proto-Oncogene Proteins c-fos/metabolism , Rats , Rats, Transgenic/metabolism , Receptors, Dopamine D1/metabolism , Receptors, Dopamine D2/metabolism , Social Behavior , Ventral Tegmental Area/metabolism
8.
Biomolecules ; 11(12)2021 12 02.
Article in English | MEDLINE | ID: mdl-34944458

ABSTRACT

Diacylglycerol kinase ß (DGKß) is an enzyme that converts diacylglycerol to phosphatidic acid and is mainly expressed in the cerebral cortex, hippocampus and striatum. We previously reported that DGKß induces neurite outgrowth and spinogenesis, contributing to higher brain functions, including emotion and memory. To elucidate the mechanisms involved in neuronal development by DGKß, we investigated the importance of DGKß activity in the induction of neurite outgrowth using human neuroblastoma SH-SY5Y cells. Interestingly, both wild-type DGKß and the kinase-negative (KN) mutant partially induced neurite outgrowth, and these functions shared a common pathway via the activation of mammalian target of rapamycin complex 1 (mTORC1). In addition, we found that DGKß interacted with the small GTPase RalA and that siRNA against RalA and phospholipase D (PLD) inhibitor treatments abolished DGKßKN-induced neurite outgrowth. These results indicate that binding of RalA and activation of PLD and mTORC1 are involved in DGKßKN-induced neurite outgrowth. Taken together with our previous reports, mTORC1 is a key molecule in both kinase-dependent and kinase-independent pathways of DGKß-mediated neurite outgrowth, which is important for higher brain functions.


Subject(s)
Neuronal Outgrowth , Phospholipase D , Corpus Striatum , Hippocampus
9.
Mol Brain ; 14(1): 149, 2021 10 11.
Article in English | MEDLINE | ID: mdl-34629097

ABSTRACT

The generation of mature synaptic structures using neurons differentiated from human-induced pluripotent stem cells (hiPSC-neurons) is expected to be applied to physiological studies of synapses in human cells and to pathological studies of diseases that cause abnormal synaptic function. Although it has been reported that synapses themselves change from an immature to a mature state as neurons mature, there are few reports that clearly show when and how human stem cell-derived neurons change to mature synaptic structures. This study was designed to elucidate the synapse formation process of hiPSC-neurons. We propagated hiPSC-derived neural progenitor cells (hiPSC-NPCs) that expressed localized markers of the ventral hindbrain as neurospheres by dual SMAD inhibition and then differentiated them into hiPSC-neurons in vitro. After 49 days of in vitro differentiation, hiPSC-neurons significantly expressed pre- and postsynaptic markers at both the transcript and protein levels. However, the expression of postsynaptic markers was lower than in normal human or normal rat brain tissues, and immunostaining analysis showed that it was relatively modest and was lower than that of presynaptic markers and that its localization in synaptic structures was insufficient. Neurophysiological analysis using a microelectrode array also revealed that no synaptic activity was generated on hiPSC-neurons at 49 days of differentiation. Analysis of subtype markers by immunostaining revealed that most hiPSC-neurons expressed vesicular glutamate transporter 2 (VGLUT2). The presence or absence of NGF, which is required for the survival of cholinergic neurons, had no effect on their cell fractionation. These results suggest that during the synaptogenesis of hiPSC-neurons, the formation of presynaptic structures is not the only requirement for the formation of postsynaptic structures and that the mRNA expression of postsynaptic markers does not correlate with the formation of their mature structures. Technically, we also confirmed a certain level of robustness and reproducibility of our neuronal differentiation method in a multicenter setting, which will be helpful for future research. Synapse formation with mature postsynaptic structures will remain an interesting issue for stem cell-derived neurons, and the present method can be used to obtain early and stable quality neuronal cultures from hiPSC-NPCs.


Subject(s)
Induced Pluripotent Stem Cells/cytology , Neural Stem Cells/cytology , Neurogenesis , Animals , Biomarkers , Cell Culture Techniques/methods , Cell Line , Hippocampus/cytology , Humans , Induced Pluripotent Stem Cells/drug effects , Nerve Growth Factor/pharmacology , Nerve Tissue Proteins/analysis , Neural Stem Cells/ultrastructure , Neurons/chemistry , Neurons/classification , Neurons/cytology , Neuropeptides/analysis , Presynaptic Terminals/ultrastructure , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , Rats , Reproducibility of Results , Synapses/physiology , Vesicular Glutamate Transport Protein 1/analysis , Vesicular Glutamate Transport Protein 2/analysis
10.
Neurochem Int ; 134: 104645, 2020 03.
Article in English | MEDLINE | ID: mdl-31891737

ABSTRACT

Diacylglycerol kinase ß (DGKß) is an enzyme converting DG to phosphatidic acid (PA) and is specifically expressed in neurons, especially those in the cerebral cortex, hippocampus and striatum. We previously reported that DGKß induces neurite outgrowth and spinogenesis, contributing to higher brain function including emotion and memory, and plasma membrane localization of DGKß via the C1 domain and a cluster of basic amino acids at the C-terminus is necessary for its function. To clarify the mechanisms involved in neuronal development by DGKß, we investigated whether DGKß activity induces neurite outgrowth using human neuroblastoma SH-SY5Y cells. DGKß induced neurite outgrowth by activation of mammalian target of rapamycin complex 1 (mTORC1) through a kinase-dependent pathway. In addition, in primary cultured cortical and hippocampal neurons, inhibition of mTORC1 abolished DGKß induced-neurite outgrowth, branching and spinogenesis. These results indicated that DGKß induces neurite outgrowth and spinogenesis by activating mTORC1 in a kinase-dependent pathway.


Subject(s)
Diacylglycerol Kinase/pharmacology , Mechanistic Target of Rapamycin Complex 1/metabolism , Neuronal Outgrowth/physiology , Neurons/metabolism , Corpus Striatum/drug effects , Corpus Striatum/metabolism , Hippocampus/drug effects , Hippocampus/metabolism , Humans , Neurites/drug effects , Neurites/metabolism , Neuronal Outgrowth/drug effects
11.
Transl Psychiatry ; 9(1): 181, 2019 08 01.
Article in English | MEDLINE | ID: mdl-31371697

ABSTRACT

Clozapine is an antipsychotic agent prescribed to psychotic patients exhibiting tolerance and/or resistance to the conventional antipsychotic medications that mainly drive monoamine antagonism. As the pharmacological fundamentals of its unique antipsychotic profile have been unrevealed, here, we attempted to obtain hints at this question. Here, we found that clozapine directly acts on ErbB kinases to downregulate epidermal growth factor (EGF)/neuregulin signaling. In cultured cell lines and cortical neurons, EGF-triggered ErbB1 phosphorylation was diminished by 30 µM clozapine, but not haloperidol, risperidone, or olanzapine. The neuregulin-1-triggered ErbB4 phosphorylation was attenuated by 10 µM clozapine and 30 µM haloperidol. We assumed that clozapine may directly interact with the ErbB tyrosine kinases and affect their enzyme activity. To test this assumption, we performed in vitro kinase assays using recombinant truncated ErbB kinases. Clozapine (3-30 µM) significantly decreased the enzyme activity of the truncated ErbB1, B2, and B4 kinases. Acute in vivo administration of clozapine (20 mg/kg) to adult rats significantly suppressed the basal phosphorylation levels of ErbB4 in the brain, although we failed to detect effects on basal ErbB1 phosphorylation. Altogether with the previous findings that quinazoline inhibitors for ErbB kinases harbor antipsychotic potential in animal models for schizophrenia, our present observations suggest the possibility that the micromolar concentrations of clozapine can attenuate the activity of ErbB receptor kinases, which might illustrate a part of its unique antipsychotic psychopharmacology.


Subject(s)
Antipsychotic Agents/pharmacology , Brain/drug effects , Clozapine/pharmacology , Epidermal Growth Factor/metabolism , Neuregulins/metabolism , Oncogene Proteins v-erbB/metabolism , Animals , Astrocytes/drug effects , Astrocytes/metabolism , Brain/metabolism , Cell Line, Tumor , Cell Survival/drug effects , Down-Regulation/drug effects , Humans , Male , Phosphorylation/drug effects , Rats , Rats, Sprague-Dawley , Signal Transduction/drug effects
12.
Sci Rep ; 9(1): 11904, 2019 08 15.
Article in English | MEDLINE | ID: mdl-31417118

ABSTRACT

During hibernation, mammalian cells are exposed to severe environmental stressors such as low temperature, lowered O2 supply, and glucose deficiency. The cellular metabolic rate is markedly reduced for adapting to these conditions. AMP-activated protein kinase (AMPK) senses the cellular energy status and regulates metabolism. Therefore, we examined AMPK signaling in several brain regions and peripheral tissues in hibernating chipmunk. Eukaryotic elongation factor 2 (eEF2) is a downstream target of AMPK. Phosphorylation of eEF2, indicating its inactivation, is enhanced in the cerebral cortex of hibernating chipmunks. The study indicated that the sequential regulation of AMPK-mammalian target of rapamycin complex 1-eEF2 signaling was altered and protein synthesis ability was reduced in the cerebral cortex of hibernating chipmunks.


Subject(s)
AMP-Activated Protein Kinases/metabolism , Cerebral Cortex/metabolism , Hibernation/physiology , Peptide Elongation Factor 2/metabolism , Protein Biosynthesis , Sciuridae/metabolism , Acetyl-CoA Carboxylase/metabolism , Animals , Blood Glucose/metabolism , Body Temperature , Male , Phosphorylation , Sciuridae/blood , Signal Transduction , TOR Serine-Threonine Kinases/metabolism
13.
Neurochem Res ; 44(7): 1736-1744, 2019 Jul.
Article in English | MEDLINE | ID: mdl-31037609

ABSTRACT

Recent advances in human induced pluripotent stem cells (hiPSCs) offer new possibilities for biomedical research and clinical applications. Neurons differentiated from hiPSCs may be promising tools to develop novel treatment methods for various neurological diseases. However, the detailed process underlying functional maturation of hiPSC-derived neurons remains poorly understood. Here, we analyze the developmental architecture of hiPSC-derived cortical neurons, iCell GlutaNeurons, focusing on the primary cilium, a single sensory organelle that protrudes from the surface of most growth-arrested vertebrate cells. To characterize the neuronal cilia, cells were cultured for various periods and evaluated immunohistochemically by co-staining with antibodies against ciliary markers Arl13b and MAP2. Primary cilia were detected in neurons within days, and their prevalence and length increased with increasing days in culture. Treatment with the mood stabilizer lithium led to primary cilia length elongation, while treatment with the orexigenic neuropeptide melanin-concentrating hormone caused cilia length shortening in iCell GlutaNeurons. The present findings suggest that iCell GlutaNeurons develop neuronal primary cilia together with the signaling machinery for regulation of cilia length. Our approach to the primary cilium as a cellular antenna can be useful for both assessment of neuronal maturation and validation of pharmaceutical agents in hiPSC-derived neurons.


Subject(s)
Cilia/metabolism , Cilia/ultrastructure , Induced Pluripotent Stem Cells/cytology , Neurons/cytology , ADP-Ribosylation Factors/immunology , Adenylyl Cyclases/immunology , Animals , Antibodies/immunology , Cell Line , Cilia/drug effects , Hippocampus/cytology , Hippocampus/drug effects , Humans , Hypothalamic Hormones/pharmacology , Immunohistochemistry , Lithium/pharmacology , Melanins/pharmacology , Microtubule-Associated Proteins/immunology , Neurogenesis/physiology , Neurons/drug effects , Pituitary Hormones/pharmacology , Rats, Wistar , Receptors, Somatostatin/immunology
14.
Psychiatry Res ; 270: 940-946, 2018 12.
Article in English | MEDLINE | ID: mdl-30551347

ABSTRACT

Perineuronal nets comprise chondroitin sulfate moieties and their core proteins, and their neuropathological alterations have been implicated in schizophrenia. To explore the molecular mechanism of the perineuronal net impairments in schizophrenia, we measured the immunoreactivity of chondroitin sulfate moieties, major components of perineuronal nets, in three brain regions (postmortem dorsolateral prefrontal cortex, caudate nucleus, and hippocampus) of schizophrenia patients and control subjects. Immunoblotting for chondroitin 4-sulfate and chondroitin 6-sulfate moieties revealed a significant increase in intensity of a 180 kD band of chondroitin 4-sulfate immunoreactivity in the hippocampus of patients, although we detected no significant alteration in their immunoreactivities with any other molecular sizes or in other brain regions. The levels of immunoreactivity were not correlated with postmortem interval, age, or storage time. We failed to find such an increase in a similar molecular range of the chondroitin 4-sulfate immunoreactivity in the hippocampus of the rats chronically treated with haloperidol. These results suggest that the level alteration of the chondroitin 4-sulfate moiety might contribute to the perineuronal net abnormality found in patients with schizophrenia.


Subject(s)
Chondroitin Sulfates/metabolism , Hippocampus/metabolism , Schizophrenia/metabolism , Aged , Animals , Case-Control Studies , Caudate Nucleus/metabolism , Caudate Nucleus/pathology , Extracellular Matrix/metabolism , Female , Hippocampus/pathology , Humans , Male , Middle Aged , Prefrontal Cortex/metabolism , Prefrontal Cortex/pathology , Rats , Schizophrenia/pathology
15.
Phys Rev Lett ; 121(17): 173201, 2018 Oct 26.
Article in English | MEDLINE | ID: mdl-30411939

ABSTRACT

Laser pulses can break the electronic structure symmetry of atoms and molecules by preparing a superposition of states with different irreducible representations. Here, we discover the reverse process, symmetry restoration, by means of two circularly polarized laser pulses. The laser pulse for symmetry restoration is designed as a copy of the pulse for symmetry breaking. Symmetry restoration is achieved if the time delay is chosen such that the superposed states have the same phases at the temporal center. This condition must be satisfied with a precision of a few attoseconds. Numerical simulations are presented for the C_{6}H_{6} molecule and ^{87}Rb atom. The experimental feasibility of symmetry restoration is demonstrated by means of high-contrast time-dependent Ramsey interferometry of the ^{87}Rb atom.

16.
Neurochem Res ; 43(6): 1242-1249, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29736615

ABSTRACT

The local translation, which is regulated by extracellular stimuli such as guidance molecules, in growth cones of neurons provides a molecular mechanism for axonal development. In this study, we performed immunocytochemistry together with atomic force microscopy to investigate the localization of ribosomal proteins in the growth cones of rat dorsal root ganglion (DRG) neurons. The immunoreactivity of ribosomal protein P0/1/2 and S6, and novel protein synthesis were observed in the central, sterically bulky region of growth cones. Brain derived neurotrophic factor (BDNF) reduced the eEF2 phosphorylation, indicating its activation, and enhanced protein synthesis within 30 min. The effects of BDNF were completely inhibited by rapamycin, an inhibitor of mammalian target of rapamycin (mTOR). These results indicated that BDNF rapidly activates translation and enhances novel protein synthesis in growth cones of DRG though the mTOR signaling.


Subject(s)
Brain-Derived Neurotrophic Factor/metabolism , Ganglia, Spinal/metabolism , Growth Cones/metabolism , Neurons/metabolism , Animals , Cells, Cultured , Neurogenesis/drug effects , Protein Biosynthesis/drug effects , Rats, Wistar , Signal Transduction/drug effects , Sirolimus/pharmacology , TOR Serine-Threonine Kinases/metabolism
17.
Acc Chem Res ; 51(5): 1174-1184, 2018 05 15.
Article in English | MEDLINE | ID: mdl-29733191

ABSTRACT

Coherent control is a technique to manipulate wave functions of matter with light. Coherent control of isolated atoms and molecules in the gas phase is well-understood and developed since the 1990s, whereas its application to condensed matter is more difficult because its coherence lifetime is shorter. We have recently applied this technique to condensed matter samples, one of which is solid para-hydrogen ( p-H2). Intramolecular vibrational excitation of solid p-H2 gives an excited vibrational wave function called a "vibron", which is delocalized over many hydrogen molecules in a manner similar to a Frenkel exciton. It has a long coherence lifetime, so we have chosen solid p-H2 as our first target in the condensed phase. We shine a time-delayed pair of femtosecond laser pulses on p-H2 to generate vibrons. Their interference results in modulation of the amplitude of their superposition. Scanning the interpulse delay on the attosecond time scale gives a high interferometric contrast, which demonstrates the possibility of using solid p-H2 as a carrier of information encoded in the vibrons. In the second example, we have controlled the terahertz collective phonon motion, called a "coherent phonon", of a single crystal of bismuth. We employ an intensity-modulated laser pulse, whose temporal envelope is modulated with terahertz frequency by overlap of two positively chirped laser pulses with their adjustable time delay. This modulated laser pulse is shined on the bismuth crystal to excite its two orthogonal phonon modes. Their relative amplitudes are controlled by tuning the delay between the two chirped pulses on the attosecond time scale. Two-dimensional atomic motion in the crystal is thus controlled arbitrarily. The method is based on the simple, robust, and universal concept that in any physical system, two-dimensional particle motion is decomposed into two orthogonal one-dimensional motions, and thus, it is applicable to a variety of condensed matter systems. In the third example, the double-pulse interferometry used for solid p-H2 has been applied to many-body electronic wave functions of an ensemble of ultracold rubidium Rydberg atoms, hereafter called a "strongly correlated ultracold Rydberg gas". This has allowed the observation and control of many-body electron dynamics of more than 40 Rydberg atoms interacting with each other. This new combination of ultrafast coherent control and ultracold atoms offers a versatile platform to precisely observe and manipulate nonequilibrium dynamics of quantum many-body systems on the ultrashort time scale. These three examples are digested in this Account.

18.
J Neurochem ; 142(6): 886-900, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28608461

ABSTRACT

Phenotypic development of neocortical GABA neurons is highly plastic and promoted by various neurotrophic factors such as neuregulin-1. A subpopulation of GABA neurons expresses not only neuregulin receptor (ErbB4) but also epidermal growth factor (EGF) receptor (ErbB1) during development, but the neurobiological action of EGF on this cell population is less understood than that of neuregulin-1. Here, we examined the effects of exogenous EGF on immature GABA neurons both in culture and in vivo and also explored physiological consequences in adults. We prepared low density cultures from the neocortex of rat embryos and treated neocortical neurons with EGF. EGF decreased protein levels of glutamic acid decarboxylases (GAD65 and GAD67), and EGF influences on neuronal survival and glial proliferation were negligible or limited. The EGF treatment also diminished the frequency of miniature inhibitory postsynaptic currents (mIPSCs). In vivo administration of EGF to mouse pups reproduced the above GABAergic phenomena in neocortical culture. In EGF-injected postnatal mice, GAD- and parvalbumin-immunoreactivities were reduced in the frontal cortex. In addition, postnatal EGF treatment decreased mIPSC frequency in, and the density of, GABAergic terminals on pyramidal cells. Although these phenotypic influences on GABA neurons became less marked during development, it later resulted in the reduced ß- and γ-powers of sound-evoked electroencephalogram in adults, which is regulated by parvalbumin-positive GABA neurons and implicated in the schizophrenia pathophysiology. These findings suggest that, in contrast to the ErbB4 ligand of neuregulin-1, the ErbB1 ligand of EGF exerts unique maturation-attenuating influences on developing cortical GABAergic neurons.

19.
Neurosci Lett ; 654: 99-106, 2017 Jul 27.
Article in English | MEDLINE | ID: mdl-28645787

ABSTRACT

Glial cell line-derived neurotrophic factor (GDNF) positively regulates the development and maintenance of in vitro dopaminergic neurons. However, the in vivo influences of GDNF signals on the brain dopamine system are controversial and not fully defined. To address this question, we analyzed dopaminergic phenotypes of the transgenic mice that overexpress GDNF under the control of the glial Gfap promoter. Compared with wild-type, the GDNF transgenic mice contained higher levels of GDNF protein and phosphorylated RET receptors in the brain. However, there were reductions in the levels of tyrosine hydroxylase (TH), dopamine, and its metabolite homovanillic acid in the striatum of transgenic mice. The TH reduction appeared to occur during postnatal development. Immunohistochemistry revealed that striatal TH density was reduced in transgenic mice with no apparent signs of neurodegeneration. In agreement with these neurochemical traits, basal levels of extracellular dopamine and high K+-induced dopamine efflux were decreased in the striatum of transgenic mice. We also explored the influences of GDNF overexpression on lomomotor behavior. GDNF transgenic mice exhibited lower stereotypy and rearing in a novel environment compared with wild-type mice. These results suggest that chronic overexpression of GDNF in brain astrocytes exerts an opposing influence on nigrostriatal dopamine metabolism and neurotransmission.


Subject(s)
Corpus Striatum/metabolism , Dopamine/metabolism , Glial Cell Line-Derived Neurotrophic Factor/metabolism , Animals , Locomotion/physiology , Male , Mice , Mice, Transgenic , Phenotype , Synaptic Transmission/physiology
20.
PLoS One ; 12(3): e0174780, 2017.
Article in English | MEDLINE | ID: mdl-28350885

ABSTRACT

The neurotrophic factor neuregulin 1 (NRG1) regulates neuronal development, glial differentiation, and excitatory synapse maturation. NRG1 is synthesized as a membrane-anchored precursor and is then liberated by proteolytic processing or exocytosis. Mature NRG1 then binds to its receptors expressed by neighboring neurons or glial cells. However, the molecular mechanisms that govern this process in the nervous system are not defined in detail. Here we prepared neuron-enriched and glia-enriched cultures from embryonic rat neocortex to investigate the role of neurotransmitters that regulate the liberation/release of NRG1 from the membrane of neurons or glial cells. Using a two-site enzyme immunoassay to detect soluble NRG1, we show that, of various neurotransmitters, glutamate was the most potent inducer of NRG1 release in neuron-enriched cultures. NRG1 release in glia-enriched cultures was relatively limited. Furthermore, among glutamate receptor agonists, N-Methyl-D-Aspartate (NMDA) and kainate (KA), but not AMPA or tACPD, mimicked the effects of glutamate. Similar findings were acquired from analysis of the hippocampus of rats with KA-induced seizures. To evaluate the contribution of members of a disintegrin and metalloproteinase (ADAM) families to NRG1 release, we transfected primary cultures of neurons with cDNA vectors encoding NRG1 types I, II, or III precursors, each tagged with the alkaline phosphatase reporter. Analysis of alkaline phosphatase activity revealed that the NRG1 type II precursor was subjected to tumor necrosis factor-α-converting enzyme (TACE) / a Disintegrin And Metalloproteinase 17 (ADAM17) -dependent ectodomain shedding in a protein kinase C-dependent manner. These results suggest that glutamatergic neurotransmission positively regulates the ectodomain shedding of NRG1 type II precursors and liberates the active NRG1 domain in an activity-dependent manner.


Subject(s)
Glutamates/pharmacology , Neuregulin-1/metabolism , Neurons/drug effects , Protein Precursors/metabolism , 6-Cyano-7-nitroquinoxaline-2,3-dione/pharmacology , ADAM17 Protein/metabolism , Acetylcholine/pharmacology , Animals , Blotting, Western , Cell Membrane/drug effects , Cell Membrane/metabolism , Cells, Cultured , Dipeptides/pharmacology , Dose-Response Relationship, Drug , Enzyme-Linked Immunosorbent Assay , Kainic Acid/pharmacology , N-Methylaspartate/pharmacology , Neurons/metabolism , Prosencephalon/cytology , Protein Kinase C/metabolism , Proteolysis/drug effects , Rats, Sprague-Dawley , Serotonin/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...